{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T17:59:41Z","timestamp":1769104781287,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2023KY050"],"award-info":[{"award-number":["2023KY050"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.clcc.2025.01.005","type":"journal-article","created":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T18:12:59Z","timestamp":1738433579000},"page":"248-255.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic Value of External Iliac Lymph Node (N1b) Metastasis in Anal Carcinoma and Validation of a New Stage Grouping System"],"prefix":"10.1016","volume":"24","author":[{"given":"Hong'en","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weixuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingchen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo'an","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5579-7115","authenticated-orcid":false,"given":"Tao","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clcc.2025.01.005_bib0001","first-page":"516","article-title":"Survival outcomes used to generate version 9 American Joint Committee on Cancer staging system for anal cancer","volume":"73","author":"Janczewski","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clcc.2025.01.005_bib0002","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1080\/0284186X.2020.1778180","article-title":"Evaluation of the stage classification of anal cancer by the TNM 8th version versus the TNM 7th version","volume":"59","author":"Dahl","year":"2020","journal-title":"Acta Oncol"},{"key":"10.1016\/j.clcc.2025.01.005_bib0003","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/S1470-2045(17)30456-4","article-title":"Nodal stage migration and prognosis in anal cancer: a systematic review, meta-regression, and simulation study","volume":"18","author":"Sekhar","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clcc.2025.01.005_bib0004","doi-asserted-by":"crossref","first-page":"852","DOI":"10.6004\/jnccn.2018.0060","article-title":"Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology","volume":"16","author":"Benson","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.clcc.2025.01.005_bib0005","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/jjco\/hyy198","volume":"49","author":"Shida","year":"2019","journal-title":"JPN J Clin Oncol"},{"key":"10.1016\/j.clcc.2025.01.005_bib0006","doi-asserted-by":"crossref","first-page":"653","DOI":"10.6004\/jnccn.2023.0030","article-title":"Anal Carcinoma, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology","volume":"21","author":"Benson","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.clcc.2025.01.005_bib0007","doi-asserted-by":"crossref","first-page":"e70119","DOI":"10.1002\/cam4.70119","article-title":"Comparison of the TNM9th and 8th editions for localized and locally advanced anal squamous cell carcinoma treated nonsurgically and proposal of a new stage grouping system","volume":"13","author":"Zheng","year":"2024","journal-title":"Cancer Med"},{"key":"10.1016\/j.clcc.2025.01.005_bib0008","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.mric.2019.09.005","article-title":"Staging of anal cancer: role of MR imaging","volume":"28","author":"Maas","year":"2020","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"10.1016\/j.clcc.2025.01.005_bib0009","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/jnci\/djae195","article-title":"Treatment of stages I-III squamous cell anal cancer: a comparative effectiveness systematic review","volume":"117","author":"Troester","year":"2025","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clcc.2025.01.005_bib0010","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/1097-0142(19830401)51:7<1291::AID-CNCR2820510719>3.0.CO;2-R","article-title":"Depth of invasion, location, and size of cancer of the anus dictate operative treatment","volume":"51","author":"Schraut","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.clcc.2025.01.005_bib0011","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1136\/ijgc-2020-001973","article-title":"Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB-IVA: oncologic results of a prospective randomized international multicenter (Uterus-11) intergroup study","volume":"30","author":"Marnitz","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.clcc.2025.01.005_bib0012","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ijrobp.2005.02.030","article-title":"Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome","volume":"63","author":"Milano","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clcc.2025.01.005_bib0013","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1186\/s12885-022-09729-4","article-title":"Prognostic factors for patients with anal cancer treated with conformal radiotherapy-a systematic review","volume":"22","author":"Theophanous","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clcc.2025.01.005_bib0014","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ijrobp.2008.08.070","article-title":"Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas","volume":"74","author":"Myerson","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clcc.2025.01.005_bib0015","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.ijrobp.2011.12.058","article-title":"Australasian Gastrointestinal Trials Group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer","volume":"83","author":"Ng","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clcc.2025.01.005_bib0016","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.prro.2022.01.015","article-title":"ECOG-ACRIN guideline for contouring and treatment of early stage anal cancer using IMRT\/IGRT","volume":"12","author":"Damico","year":"2022","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.clcc.2025.01.005_bib0017","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijrobp.2021.08.008","article-title":"Long-term outcomes of NRG oncology\/RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in Anal Canal cancer","volume":"112","author":"Kachnic","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clcc.2025.01.005_bib0018","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13014-020-01567-7","article-title":"Patterns of recurrence in anal cancer: a detailed analysis","volume":"15","author":"Nilsson","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.clcc.2025.01.005_bib0019","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.ijrobp.2021.02.053","article-title":"Involved-field irradiation in definitive chemoradiotherapy for locoregional esophageal squamous cell carcinoma: results from the ESO-Shanghai 1 trial","volume":"110","author":"Zhu","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clcc.2025.01.005_bib0020","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1038\/s41467-021-24288-1","article-title":"Induction chemotherapy followed by definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma: a randomized phase II trial","volume":"12","author":"Liu","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.clcc.2025.01.005_bib0021","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/cac2.12601","article-title":"Concurrent chemoradiotherapy of different radiation doses and different irradiation fields for locally advanced thoracic esophageal squamous cell carcinoma: a randomized, multicenter, phase III clinical trial","volume":"44","author":"Zhang","year":"2024","journal-title":"Cancer Commun (Lond)"},{"issue":"1","key":"10.1016\/j.clcc.2025.01.005_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0317598","article-title":"Comparative evaluation of TNM staging systems (eighth vs. ninth edition) for the non-surgical treatment of localized and locally advanced anal squamous cell carcinoma: prognostic significance of T classification and lymph node status","volume":"20","author":"Zheng","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.clcc.2025.01.005_bib0023","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/cncr.27825","article-title":"Prognostic factors for recurrence and survival in anal cancer: generating hypotheses from the mature outcomes of the first United Kingdom Coordinating Committee on Cancer Research Anal Cancer Trial (ACT I)","volume":"119","author":"Glynne-Jones","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.clcc.2025.01.005_bib0024","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","article-title":"Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin","volume":"30","author":"Gunderson","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2025.01.005_bib0025","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.radonc.2018.08.008","article-title":"Prognostic factors of colostomy free survival in patients presenting with locally advanced anal canal carcinoma: a pooled analysis of two prospective trials (KANAL 2 and ACCORD 03)","volume":"129","author":"Faivre","year":"2018","journal-title":"Radiother Oncol"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002825000155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002825000155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T01:20:07Z","timestamp":1769044807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002825000155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1533002825000155"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2025.01.005","relation":{},"ISSN":["1533-0028"],"issn-type":[{"value":"1533-0028","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Value of External Iliac Lymph Node (N1b) Metastasis in Anal Carcinoma and Validation of a New Stage Grouping System","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2025.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}